MESH Core 2026
Our two-day intensive, in-person, hands-on healthcare innovation course in the mecca of biomedical innovation - greater Boston - is designed on decades of cutting-edge innovation on the fringes.Suitable for startups, physicians, researchers, investors, allied health professionals, MBAs, students, executives, and the public. A combination of lectures, hands-on cases, extensive networking, lively panels, and startup pitch sessions.
Target Audience
This activity is intended for physicians & allied health professionals, researchers & academic innovators, startups & entrepreneurs in healthcare, early-career professionals in healthcare innovation, and students.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Apply innovative strategies and emerging technologies like AI and digital health to address healthcare challenges.
- Integrate interprofessional disciplines to enhance teamwork in biomedical innovation, ensuring successful cross-disciplinary collaboration.
- Improve Patient Outcomes: Analyze new healthcare solutions and learn to employ these solutions to exemplify high quality patient care and outcomes.
Additional Information

Keynote Speakers & Faculty
Marc Succi, MD - Founder and Executive Director, MESH Incubator; MESH Core Course Director; Associate Professor, Harvard Medical School
Chris Coburn - Chief Innovation Officer, Mass General Brigham
Jason Kelly, PhD - Co-Founder and CEO at Ginkgo Bioworks; former Chair of the US National Security Commission on Emerging Biotechnology
Pete Clardy, MD - Director, Clinical Enterprise, Google Health; Pulmonary and Critical Care Physician
Ben Robbins, MD, MBA - General Partner, Google Ventures
Ian Chiang, MBA - Partner, Flare Capital Partners
Shantanu Gaur, MD - Co-Founder & CEO at Allurion
Jill Kravetz, MBA - Bruce and Bridgitt Evans Executive Director, Harvard Innovation Labs
Andrew W. Lo, PhD - Professor of Finance & Director of the Laboratory for Financial Engineering, MIT Sloan School of Management
Amitabh Chandra, PhD MBA - Henry and Allison McCance Professor of Business Administration, Harvard Business School
Katie Coffman, PhD - Piramal Associate Professor of Business Administration, Harvard Business School
Ken Itrato, JD - Partner, Crowell & Moring
Ian Johnston, PhD - Vice President of Tech Translation and Ecosystem Development, MIT The Engine
Thomas Eisenmann, PhD, MBA - Howard H. Stevenson Professor of Business Administration, Harvard Business School; Peter O. Crisp Faculty Chair, Harvard Innovation Labs, Faculty Co-chair of HBS Rock Center for Entrepreneurship, Harvard Business School
Liz Kwo, MD, MBA, MPH - President, Vanna Health
Leo Anthony Celi, MD, MS, MPH - Senior Research Scientist, MIT Clinical Research Director, Laboratory of Computational Physiology; Co-Director, MIT Sana; Associate Professor of Medicine, Part-time, Harvard Medical School
Keith J. Figlioli, MBA MPH - Managing Partner, LRVHealth
James Stanford, MBA - Managing Director, Fitzroy Health
Ken Zolot - Senior Lecturer, Massachusetts Institute of Technology
Richard Berenson, JD, MBA - Managing Director , Venzyme Catalyst, LLC; Executive Committee, Mass Medical Angels
Lesley Solomon, MBA - Founder and CEO, Veda Clinical Trials
Melissa Palchak Opraseuth, PharmD - CEO, par8o
Suzy McKinney, MD - Chief Medical Officer, V1ewpoint
Roger Kitterman, MBA - Senior Vice President, Venture, Business Development and Licensing, Mass General Brigham Innovation
Mike Freni, MBA - Vice President of Business Development, Mass General Brigham Innovation
Angela Shen, MD, MBA - Vice President, Head of Regulatory, Gene and Cell Therapy Institute at Mass General Brigham
Nimra Taqi - Vice President of Business Development and Licensing, Mass General Brigham Innovation
Brian Zamarron, PhD - Director, Business Development & Licensing, Mass General Brigham Innovation
Omar Y Kudsi, MD, MBA - Surgeon, Brigham & Women's Hospital
Gerald Hefferman, MD - Neuroradiologist, Brigham and Women’s Hospital
Sherene Shenouda, PhD - Director, Business Development & Licensing, Mass General Brigham Innovation
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM
Mass General Brigham designates this live activity for a maximum of 14.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 16.25 AMA PRA Category 1 Credit™
- 16.25 Participation

Facebook
X
LinkedIn
Forward